Obesity Is a Related Factor With Severe COVID-19 Pneumonia in Children: A Case Series
Pediatric Infection and Vaccine
; 29(2):77-83, 2022.
Article
in English
| EMBASE | ID: covidwho-2044252
ABSTRACT
A small proportion of children with coronavirus disease 2019 (COVID-19) develop severe pneumonia. We reported the severe COVID-19 pneumonia in children aged <18 years with COVID-19 treated with remdesivir and dexamethasone from August 2021 to November 2021 by a retrospective review of their medical records. Eight children were included (5 males and 3 females). Their median age was 16 years (range 9 to 17 years) and their median body mass index was 30.5 kg/m2 (range 22.8–38.5 kg/m2). All patients had fever and dyspnea with hypoxia. Chest radiographic findings were variable and included diffuse or multifocal consolidation, nodules, and ground-glass opacities in the lungs. After receiving intravenous remdesivir and dexamethasone, 7 of the 8 children experienced an improvement in their symptoms within 2 days. In our case series, obesity was present in 6 out of 8 children with severe COVID-19 pneumonia.
adolescent; article; body mass; case study; child; clinical article; coronavirus disease 2019; drug combination; drug therapy; dyspnea; female; fever; ground glass opacity; human; hypoxia; intravenous drug administration; male; medical record; obesity; pneumonia; retrospective study; thorax; dexamethasone; remdesivir
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Pediatric Infection and Vaccine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS